Jiangsu Nanfang Medical Co., Ltd. (603880) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jiangsu Nanfang Medical Co., Ltd.

Why is Jiangsu Nanfang Medical Co., Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.73%

Poor long term growth as Net Sales has grown by an annual rate of -9.56% and Operating profit at -216.07% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Negative results in Mar 25

INTEREST(HY) At CNY 24.1 MM has Grown at 44.35%
NET PROFIT(9M) At CNY -199.61 MM has Grown at -28.89%
ROCE(HY) Lowest at -53.97%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 31.85%, its profits have fallen by -32.1%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangsu Nanfang Medical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Jiangsu Nanfang Medical Co., Ltd.

31.85%

1.36

46.23%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-9.56%

EBIT Growth (5y)

-216.07%

EBIT to Interest (avg)

0.22

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.59

Sales to Capital Employed (avg)

0.62

Tax Ratio

4.86%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

3.73%

ROE (avg)

2.75%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.31

EV to EBIT

-10.80

EV to EBITDA

-14.81

EV to Capital Employed

3.05

EV to Sales

3.50

PEG Ratio

Dividend Yield

ROCE (Latest)

-28.24%

ROE (Latest)

-76.94%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 85.92 MM

NET SALES(HY)

At CNY 315.06 MM has Grown at 18.73%

INVENTORY TURNOVER RATIO(HY)

Highest at 3.01%

DEBTORS TURNOVER RATIO(HY)

Highest at 3.69%

PRE-TAX PROFIT(Q)

At CNY -10.22 MM has Grown at 80.44%

NET PROFIT(Q)

At CNY -7.92 MM has Grown at 83.39%

-16What is not working for the Company

INTEREST(HY)

At CNY 24.1 MM has Grown at 44.35%

NET PROFIT(9M)

At CNY -199.61 MM has Grown at -28.89%

ROCE(HY)

Lowest at -53.97%

DEBT-EQUITY RATIO (HY)

Highest at 159.06 %

RAW MATERIAL COST(Y)

Grown by 6.79% (YoY

CASH AND EQV(HY)

Lowest at CNY 127.7 MM

Here's what is working for Jiangsu Nanfang Medical Co., Ltd.

Operating Cash Flow

Highest at CNY 85.92 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 169.07 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -10.22 MM has Grown at 80.44%

over average net sales of the previous four periods of CNY -52.27 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -7.92 MM has Grown at 83.39%

over average net sales of the previous four periods of CNY -47.67 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Inventory Turnover Ratio

Highest at 3.01%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 3.69%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Jiangsu Nanfang Medical Co., Ltd.

Interest

At CNY 24.1 MM has Grown at 44.35%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at 159.06 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at CNY 127.7 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost

Grown by 6.79% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales